Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: A90- Dengue fever [classical dengue] Health Condition 3: B978- Other viral agents as the cause ofdiseases classified elsewhere
Conditions
Interventions
Intervention1: NA: NA
Sponsors
National Biopharma Mission NBM Biotechnology Industry Research Assistance Council BIRAC
Eligibility
Inclusion criteria
Inclusion criteria: Survey will be carried out in individuals above 2 years of age and all individuals currently residing and likely to stay till the end of study (1 year) in the study area will be considered eligible for inclusion.
Exclusion criteria
Exclusion criteria: Consent refusal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Determining the burden of COVID 19 infection at the community level and monitor the trends in transmission of SARS-CoV-2 infection. 2.Risk factors for infection can be identified which might inform future control strategies.Timepoint: Outcome 1: 12 months Outcome 2: 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The serial surveys in the same set of individuals will help in measuring the antibody levels over a period of time and understand the proportion of individuals who are able to mount a neutralisation response and the duration for which immunity lasts after infection.Timepoint: 12 months | — |
Countries
India
Contacts
Public ContactDrYuvarajJayaraman
Indian Council of Medical Research-National Institute of Epidemiology
Outcome results
None listed